Ozlem Goker-Alpan - Lysosomal & Rare Disorder Research & Treatment Center Inc

基本信息

Career Trajectory

Bio

Mission and Vision LDRTC uses the latest research to unravel underlying disease-causing mechanisms, discover new biomarkers, and explore new therapeutic pathways and treatment options for persons suffering from lysosomal and other rare diseases. We provide comprehensive medical care and consultation for individuals with various LSDs nationwide and internationally. Our center serves as a platform for patients and families affected by these debilitating disorders.

Research Interests

Papers共 256 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Bone Resorption Biomarkers and Proinflammatory Cytokines in Gaucher Disease

Julia Dao, Neala Loynab, Sohailla Noor,Ozlem Goker-Alpan,Margarita Ivanova

MOLECULAR GENETICS AND METABOLISMno. 2 (2024)

Cited0Views0Bibtex

Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry

Deborah Elstein,Nadia Belmatoug,Bruno Bembi,Patrick Deegan,Diego Fernandez-Sasso,Pilar Giraldo,Ozlem Goker-Alpan,Derralynn Hughes,Heather Lau,Elena Lukina,Shoshana Revel-Vilk,Ida Vanessa D. Schwartz,Majdolen Istaiti,Jaco Botha,Noga Gadir,Joern Schenk,Ari Zimran

JOURNAL OF CLINICAL MEDICINEno. 12 (2024)

Cited0Views0WOSBibtex

Characteristics and Management of US Pediatric Patients with Gaucher Disease from the Gaucher Outcome Survey

Ozlem Goker-Alpan,Andrew Burrow,Gregory M. Enns,Can Ficicioglu,Priya S. Kishnani,Damara Ortiz,Carlos E. Prada,Divya Vats,Neal J. Weinreb, Ian Robinson,Ravi R. Pathak,Ekaterina Wright,Jaco Botha,William R. Wilcox

MOLECULAR GENETICS AND METABOLISMno. 2 (2024)

Cited0Views0Bibtex

Is Gaucher Disease in Children a Continuum of Phenotype, a Hypothesis or is It Clinically Evidence-Based? Analysis of Egyptian and American Cohorts

Magy Abdelwahab,Aimee Donald,Ozlem Goker Alpan

MOLECULAR GENETICS AND METABOLISMno. 2 (2024)

Cited0Views0Bibtex

The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease

Margarita M. Ivanova,Julia Dao, Neala Loynab, Sohailla Noor,Neil Kasaci,Andrew Friedman,Ozlem Goker-Alpan

CELLS（2024）

Cited0Views0WOSBibtex

Lyso-Gb1 Acts As a Danger-Associated Molecular Pattern (DAMP) to Induce Cell Death and Autonomous Disease Progression, Indicating the Role of Additional Therapeutics in Gaucher Disease

Neil Kasaci,Julia Dao, Claire Zhang, Neala Loynab,Lauren Noll,Andrew Friedman,Margarita Ivanova,Ozlem Goker-Alpan

MOLECULAR GENETICS AND METABOLISM（2024）

Cited0Views0Bibtex

Fabry Patient's Experience of Pegunigalsidase Alfa Monthly Infusion: PEOPLE Study

Ankit Mehta,Francois J. Eyskens,Antonio Pisani,Ulla Feldt-Rasmussen,Derralynn Hughes,Patrick B. Deegan,Ozlem Goker-Alpan,Eric Wallace,John Bernat,Nicola Longo, Francesco Bianchi,Rossana Rocco, Ylenia Paleari

MOLECULAR GENETICS AND METABOLISMno. 2 (2024)

Cited0Views0Bibtex

GBA1-Associated Parkinson’s Disease is a Distinct Entity

Aliaksandr Skrahin,Mia Horowitz,Majdolen Istaiti,Volha Skrahina,Jan Lukas,Gilad Yahalom,Mikhal E Cohen,Shoshana Revel-Vilk,Ozlem Goker-Alpan,Michal Becker-Cohen,Sharon Hassin-Baer,Per Svenningsson,Arndt Rolfs,Ari Zimran

International journal of molecular sciences（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn